Asian Institute of Medical Science (AIMS), the premium super-speciality tertiary care hospital in Delhi NCR has installed Roche Diagnostics’ fully automated latest state-of-the-art technology- cobas pro e801 and cobas pure e402 to enhance healthcare delivery and patient experience. The technologies offer a wider assay menu including Thyroid, fertility, cardiac, cancer, infectious, vitamins others. The installation ceremony was graced by Padmashree and BC Roy Award, Dr N K Pandey, Chairman and Managing Director, Asian Institute of Medical Sciences, Dr Prashant Pandey, Director – Medical Services, Mr. Anupam Pandey-Director Administration and Dr. Uma Rani, HOD, Laboratory Medicine.
Today, one can see a paradigm shift in patients’ expectations, especially when it comes to healthcare. They are aware of the conveniences and enhanced service quality that medical technology can offer. In terms of diagnostics, COVID-19 pandemic has changed the perception about health, preventive care and the value of diagnostics. Patients today are more aware of the role of diagnostic tests for maintaining their general health. This sets a new benchmark for large healthcare institutes to opt for technology that enhances efficiency and ensures patient satisfaction. In this regard, Asian Institute of Medical Sciences has gone leaps and bounds to deliver its mission of bringing quality healthcare services for all. The institute has earnestly and continuously strived to scale newer heights in the pursuit of excellence and successfully attained the highest standards of healthcare along with administrative efficiency, which has led to its accreditation from NABH and NABL.
Speaking at the occasion Dr Uma Rani, HOD, Laboratory Medicine, said, “ Diagnostics play a crucial role at every step of disease management – diagnosis, monitoring, screening and prognosis and at AIMS, we are committed to ensure highest possible personalized patient care. With the installation of cobas pro e801 and cobas pure e402 we will be able to provide for a larger patient group and address a wide range of disease areas. We are extremely delighted to have collaborated with Roche Diagnostics as this will help us enhance the accuracy and speed of test results for our patients ”
Using the cobas® solutions will enable the institute to further enhance testing in the realms of endocrinology, immunology, and metabolic diseases. These instruments can facilitate the smallest sample volume in the industry on immunology with shorter Turnaround Time (TAT). Through automation, Roche Diagnostics’ new solutions are designed to simplify workflows and improve productivity of lab personnel whilst also supporting the delivery of better patient care.